Top

Published in:

01-04-2015 | Clinical study

Risks and benefits of discontinuing statins in advanced illness

Published in: Reactions Weekly | Issue 1/2015

Excerpt

Deprescribing HMG-CoA reductase inhibitors (statins) appears to be safe in patients receiving palliative care, and may improve quality of life (QOL) and reduce costs, according to the findings of a study published in JAMA Internal Medicine.1 …

2012 US dollars

Kutner JS, et al. Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness: A Randomized Clinical Trial. JAMA Internal Medicine : 23 Mar 2015. Available from: URL: http://doi.org/10.1001/jamainternmed.2015.0289.

Holmes HM, et al. Evidence-Based Deprescribing of Statins in Patients With Advanced Illness. JAMA Internal Medicine : 23 Mar 2015. Available from: URL: http://archinte.jamanetwork.com/article.aspx?articleid=2204031.

Scott IA, et al. Reducing Inappropriate Polypharmacy -- The Process of Deprescribing. JAMA Internal Medicine : 23 Mar 2015. Available from: URL: http://archinte.jamanetwork.com/article.aspx?articleid=2204035.

Title: Risks and benefits of discontinuing statins in advanced illness
Publication date: 01-04-2015
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2015
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-015-9102-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Risks and benefits of discontinuing statins in advanced illness

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2015

Thyrotropin-α

Vismodegib

Caspofungin/micafungin

Prednisolone

Trastuzumab

Afamelanotide